Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model

Frontiers in Aging Neuroscience

Volumn 5, Issue OCT, 2013, Pages

  Cheng, Xiao Rui ^a   Cui, Xiu Liang ^b   Zheng, Yue ^a   Zhang, Gui Rong ^a   Li, Peng ^b   Huang, Huang ^a   Zhao, Yue Ying ^a   Bo, Xiao Chen ^b   Wang, Sheng Qi ^b   Zhou, Wen Xia ^a   Zhang, Yong Xiang ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Alzheimer's disease; Apoptosis; Cerebral cortex; Differential expressed genes; Hippocampus; Molecular network; Senescence accelerated mouse prone 8; Synaptic transmission

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; G PROTEIN COUPLED RECEPTOR KINASE 2; GONADORELIN; MICRORNA; MICRORNA 101; MICRORNA 106B; MICRORNA 125B; MICRORNA 155; MICRORNA 17; MICRORNA 18A; MICRORNA 20A; MICRORNA 22; MICRORNA 26A; MICRORNA 34A; NEUROTROPHIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN CORTEX; BRAIN FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; ELECTRON TRANSPORT; FOCAL ADHESION; GENE EXPRESSION; HIPPOCAMPUS; HOMEOSTASIS; LONG TERM POTENTIATION; MALE; MORPHOGENESIS; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; REGULATORY MECHANISM; SENESCENCE; SMOOTH MUSCLE CONTRACTION; SYNAPTIC TRANSMISSION; VASCULAR SMOOTH MUSCLE; WNT SIGNALING PATHWAY;

EID: 84895831104     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00065     Document Type: Article

References (161)

1. Agostini, M., Tucci, P., Killick, R., Candi, E., Sayan, B. S., Rivetti di Val Cervo, P., et al. (2011). Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc. Natl. Acad. Sci. U.S.A. 108, 21093-21098. doi: 10.1073/pnas.1112061109.
2. Antonov, A. V., Dietmann, S., Rodchenkov, I., and Mewes, H. W. (2009). PPI spider: a tool for the interpretation of proteomics data in the context of protein-protein interaction networks. Proteomics 9, 2740-2749. doi: 10.1002/pmic.200800612.
3. Barral, S., Bird, T., Goate, A., Farlow, M. R., Diaz-Arrastia, R., Bennett, D. A., et al. (2012). Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology 78, 1464-1471. doi: 10.1212/WNL.0b013e3182553c48.
4. Bekinschtein, P., Cammarota, M., Igaz, L. M., Bevilaqua, L. R., Izquierdo, I., and Medina, J. H. (2007). Persistence of long-term memory storage requires a late protein synthesis-and BDNF-dependent phase in the hippocampus. Neuron 53, 261-277. doi: 10.1016/j.neuron.2006.11.025.
5. Berenguer, J., Herrera, A., Vuolo, L., Torroba, B., Llorens, F., Sumoy, L., et al. (2013). MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors. Mol. Cell. Biol. 33, 2706-2717. doi: 10.1128/MCB.00338-13.
6. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23. doi: 10.1038/ng1934.
7. Bickeboller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., et al. (1997). Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am. J. Hum. Genet. 60, 439-446.
8. Brock, M., Trenkmann, M., Gay, R. E., Gay, S., Speich, R., and Huber, L. C. (2011). MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J. Biol. Chem. 286, 40142-40150. doi: 10.1074/jbc. M111.251793.
9. Butterfield, D. A., and Poon, H. F. (2005). The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp. Gerontol. 40, 774-783. doi: 10.1016/j.exger.2005.05.007.
10. Canudas, A. M., Gutierrez-Cuesta, J., Rodriguez, M. I., Acuna-Castroviejo, D., Sureda, F. X., Camins, A., et al. (2005). Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech. Ageing Dev. 126, 1300-1304. doi: 10.1016/j.mad.2005.07.008.
11. Carrasquillo, M. M., Belbin, O., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., et al. (2010). Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch. Neurol. 67, 961-964. doi: 10.1001/archneurol.2010.147.
12. Carter, T. A., Greenhall, J. A., Yoshida, S., Fuchs, S., Helton, R., Swaroop, A., et al. (2005). Mechanisms of aging in senescence-accelerated mice. Genome Biol. 6:R48. doi: 10.1186/gb-2005-6-6-r48.
13. Casadesus, G., Gutierrez-Cuesta, J., Lee, H. G., Jimenez, A., Tajes, M., Ortuno-Sahagun, D., et al. (2012). Neuronal cell cycle re-entry markers are altered in the senescence accelerated mouse P8 (SAMP8). J. Alzheimers Dis. 30, 573-583. doi: 10.3233/JAD-2012-120112.
14. Chan, S. Y., White, K., and Loscalzo, J. (2012). Deciphering the molecular basis of human cardiovascular disease through network biology. Curr. Opin. Cardiol. 27, 202-209. doi: 10.1097/HCO.0b013e3283515b31.
15. Chang, J., Rimando, A., Pallas, M., Camins, A., Porquet, D., Reeves, J., et al. (2012). Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiol. Aging 33, 2062-2071. doi: 10.1016/j.neurobiolaging.2011.08.015.
16. Chang, T. C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., et al. (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752. doi: 10.1016/j.molcel.2007.05.010.
17. Chen, Q. R., Yu, L. R., Tsang, P., Wei, J. S., Song, Y. K., Cheuk, A., et al. (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J. Proteome Res. 10, 479-487. doi: 10.1021/pr1006697.
18. Chen, Y., Zhu, J., Lum, P. Y., Yang, X., Pinto, S., MacNeil, D. J., et al. (2008). Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435. doi: 10.1038/nature06757.
19. Cheng, X. R., Yang, Y., Zhou, W. X., and Zhang, Y. X. (2011). Expression of VGLUTs contributes to degeneration and acquisition of learning and memory. Neurobiol. Learn. Mem. 95, 361-375. doi: 10.1016/j.nlm.2011.01.010.
20. Cheng, X. R., Zhou, W. X., and Zhang, Y. X. (2007a). The effects of Liuwei Dihuang decoction on the gene expression in the hippocampus of senescence-accelerated mouse. Fitoterapia 78, 175-181. doi: 10.1016/j.fitote.2006.11.006.
21. Cheng, X. R., Zhou, W. X., Zhang, Y. X., Zhou, D. S., Yang, R. F., and Chen, L. F. (2007b). Differential gene expression profiles in the hippocampus of senescence-accelerated mouse. Neurobiol. Aging 28, 497-506. doi:10.1016/j.neurobiolaging.2006.02.004.
22. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
23. Corneveaux, J. J., Myers, A. J., Allen, A. N., Pruzin, J. J., Ramirez, M., Engel, A., et al. (2010). Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet. 19, 3295-3301. doi: 10.1093/hmg/ddq221.
24. Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 103, 7024-7029. doi: 10.1073/pnas.0602266103.
25. Degos, V., Peineau, S., Nijboer, C., Kaindl, A. M., Sigaut, S., Favrais, G., et al. (2013). G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration. Ann. Neurol. 73, 667-678. doi: 10.1002/ana.23868.
26. del Valle, J., Bayod, S., Camins, A., Beas-Zarate, C., Velazquez-Zamora, D. A., Gonzalez-Burgos, I., et al. (2012). Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer's disease. J. Alzheimers Dis. 32, 233-240. doi: 10.3233/JAD-2012-120718.
27. Delay, C., Calon, F., Mathews, P., and Hebert, S. S. (2011). Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol. Neurodegener. 6, 70. doi: 10.1186/1750-1326-6-70.
28. Devi, L., and Ohno, M. (2012). 7, 8-dihydroxyflavone, a small-molecule Trkagonist, B, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 37, 434-444. doi: 10.1038/npp.2011.191.
29. Diez-Vives, C., Gay, M., Garcia-Matas, S., Comellas, F., Carrascal, M., Abian, J., et al. (2009). Proteomic study of neuron and astrocyte cultures from senescence-accelerated mouse SAMP8 reveals degenerative changes. J. Neurochem. 111, 945-955. doi: 10.1111/j.1471-4159.2009.06374.x.
30. Dobarro, M., Orejana, L., Aguirre, N., and Ramirez, M. J. (2013). Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model. Neuropharmacology 64, 137-144. doi: 10.1016/j.neuropharm.2012.06.047.
31. Dobrin, R., Zhu, J., Molony, C., Argman, C., Parrish, M. L., Carlson, S., et al. (2009). Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biol. 10, R55. doi: 10.1186/gb-2009-10-5-r55.
32. Edwards-Lee, T., Wen, J., Bell, J., Hardy, J., Chung, J., and Momeni, P. (2006). A presenilin-1 mutation (T245P) in transmembrane domain 6 causes early onset Alzheimer's disease. Neurosci. Lett. 398, 251-252. doi: 10.1016/j.neulet.2006.01.006.
33. Elias-Sonnenschein, L. S., Viechtbauer, W., Ramakers, I. H., Verhey, F. R., and Visser, P. J. (2011). Predictive value of APOE-epsilon4 allele for progression from MCI to AD-type dementia: a meta-analysis. J. Neurol. Neurosurg. Psychiatr. 82, 1149-1156. doi: 10.1136/jnnp.2010.231555.
34. Emanuele, E. A., D'Angelo Tomaino, C., Binetti, G., Ghidoni, R., Politi, P., et al. (2005). Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch. Neurol. 62, 1734-1736. doi: 10.1001/archneur.62.11.1734.
35. Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., et al. (2008). Genetics of gene expression and its effect on disease. Nature 452, 423-428. doi: 10.1038/nature06758.
36. Fan, X., Liu, Y., Jiang, J., Ma, Z., Wu, H., Liu, T., et al. (2010). miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim. Biophys. Sin. 42, 318-324. doi: 10.1093/abbs/gmq026.
37. Furlong, L. I. (2013). Human diseases through the lens of network biology. Trends Genet. 29, 150-159. doi: 10.1016/j.tig.2012.11.004.
38. Gandy, S., and Heppner, F. L. (2013). Microglia as dynamic and essential components of the amyloid hypothesis. Neuron 78, 575-577. doi: 10.1016/j.neuron.2013.05.007.
39. Garcia-Mesa, Y., Lopez-Ramos, J. C., Gimenez-Llort, L., Revilla, S., Guerra, R., Gruart, A., et al. (2011). Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J. Alzheimers Dis. 24, 421-454.
40. Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., et al. (2011). APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903-907. doi: 10.1038/mp.2011.52.
41. Goate, A. (2006). Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer's disease. J. Alzheimers Dis. 9, 341-347. doi: 10.1007/978-3-540-37652-1_16.
42. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706. doi: 10.1038/349704a0.
43. Gong, Y., Liu, L., Xie, B., Liao, Y., Yang, E., and Sun, Z. (2008). Ameliorative effects of lotus seedpod proanthocyanidins on cognitive deficits and oxidative damage in senescence-accelerated mice. Behav. Brain Res. 194, 100-107. doi: 10.1016/j.bbr.2008.06.029.
44. Gruart, A., Lopez-Ramos, J. C., Munoz, M. D., and Delgado-Garcia, J. M. (2008). Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. Neurobiol. Dis. 30, 439-450. doi: 10.1016/j.nbd.2008.03.001.
45. Gruart, A., Munoz, M. D., and Delgado-Garcia, J. M. (2006). Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J. Neurosci. 26, 1077-1087. doi: 10.1523/JNEUROSCI.2834-05.2006.
46. Gruart, A., Sciarretta, C., Valenzuela-Harrington, M., Delgado-Garcia, J. M., and Minichiello, L. (2007). Mutation at the TrkB PLC{gamma}-docking site affects hippocampal LTP and associative learning in conscious mice. Learn. Mem. 14, 54-62. doi: 10.1101/lm.428307.
47. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013). TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127. doi: 10.1056/NEJMoa1211851.
48. Gutierrez-Cuesta, J., Sureda, F. X., Romeu, M., Canudas, A. M., Caballero, B., Coto-Montes, A., et al. (2007). Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J. Pineal Res. 42, 394-402. doi: 10.1111/j.1600-079X.2007.00433.x.
49. Gutierrez-Cuesta, J., Tajes, M., Jimenez, A., Coto-Montes, A., Camins, A., and Pallas, M. (2008). Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model. J. Pineal Res. 45, 497-505. doi: 10.1111/j.1600-079X.2008.00626.x.
50. Hackl, M., Brunner, S., Fortschegger, K., Schreiner, C., Micutkova, L., Muck, C., et al. (2010). miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9, 291-296. doi: 10.1111/j.1474-9726.2010.00549.x.
51. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088-1093. doi: 10.1038/ng.440.
52. He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. doi: 10.1038/nature05939.
53. Hebert, S. S., Horre, K., Nicolai, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., et al. (2009). MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol. Dis. 33, 422-428. doi: 10.1016/j.nbd.2008.11.009.
54. Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J. C., Carrasquillo, M. M., et al. (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435. doi: 10.1038/ng.803.
55. Hoozemans, J. J., and O'Banion, M. K. (2005). The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs. Curr. Drug Targets. CNS Neurol. Disord. 4, 307-315. doi: 10.2174/1568007054038201.
56. Hsu, S. D., Lin, F. M., Wu, W. Y., Liang, C., Huang, W. C., Chan, W. L., et al. (2011). miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39, D163-D169. doi: 10.1093/nar/gkq1107.
57. Hu, Z. Y., Liu, G., Cheng, X. R., Huang, Y., Yang, S., Qiao, S. Y., et al. (2012). JD-30, an active fraction extracted from Danggui-Shaoyao-San, decreases beta-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice. Exp. Gerontol. 47, 14-22. doi: 10.1016/j.exger.2011.09.009.
58. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13. doi: 10.1093/nar/gkn923.
59. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57. doi: 10.1038/nprot.2008.211.
60. Huang, Y., Hu, Z., Liu, G., Zhou, W., and Zhang, Y. (2013). Cytokines induced by long-term potentiation (LTP) recording: a potential explanation for the lack of correspondence between learning/memory performance and LTP. Neuroscience 231, 432-443. doi: 10.1016/j.neuroscience.2012.11.010.
61. Huang, Y., Zhang, H., Yang, S., Qiao, H., Zhou, W., and Zhang, Y. (2012). Liuwei Dihuang decoction facilitates the induction of long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8) hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and promoting N-methyl-d-aspartate receptor (NMDA) receptors. J. Ethnopharmacol. 140, 384-390. doi: 10.1016/j.jep.2012.01.030.
62. Jahanshad, N., Rajagopalan, P., Hua, X., Hibar, D. P., Nir, T. M., Toga, A. W., et al. (2013). Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc. Natl. Acad. Sci. U.S.A. 110, 4768-4773. doi: 10.1073/pnas.1216206110.
63. Jeong, H., Mason, S. P., Barabasi, A. L., and Oltvai, Z. N. (2001). Lethality and centrality in protein networks. Nature 411, 41-42. doi: 10.1038/35075138.
64. Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., et al. (2009). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 37, D98-D104. doi: 10.1093/nar/gkn714.
65. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116. doi: 10.1056/NEJMoa1211103.
66. Jovicic, A., Zaldivar Jolissaint, J. F., Moser, R., Silva Santos Mde, F., and Luthi-Carter, R. (2013). MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms. PLoS ONE 8:e54222. doi: 10.1371/journal.pone.0054222.
67. Jun, G., Naj, A. C., Beecham, G. W., Wang, L. S., Buros, J., Gallins, P. J., et al. (2010). Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 67, 1473-1484. doi: 10.1001/archneurol.2010.201.
68. Kanno, T., Yaguchi, T., Shimizu, T., Tanaka, A., and Nishizaki, T. (2012). 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration. Lipids 47, 687-695. doi: 10.1007/s11745-012-3677-y.
69. Kim, J., Yoon, H., Ramirez, C. M., Lee, S. M., Hoe, H. S., and Fernandez-Hernando, C. (2012). MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp. Neurol. 235, 476-483. doi: 10.1016/j.expneurol.2011.11.010.
70. Kumar, V. B., Franko, M., Banks, W. A., Kasinadhuni, P., Farr, S. A., Vyas, K., et al. (2009). Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. J. Exp. Biol. 212, 494-498. doi: 10.1242/jeb.022780.
71. Kumar, V. B., Vyas, K., Franko, M., Choudhary, V., Buddhiraju, C., Alvarez, J., et al. (2001). Molecular cloning, expression, and regulation of hippocampal amyloid precursor protein of senescence accelerated mouse (SAMP8). Biochem. Cell Biol. 79, 57-67. doi: 10.1139/o00-094.
72. Lambert, J. C., Zelenika, D., Hiltunen, M., Chouraki, V., Combarros, O., Bullido, M. J., et al. (2011). Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol. Aging 32, 756 e11-e15. doi: 10.1016/j.neurobiolaging.2010.11.022.
73. Lee, J. H., Cheng, R., Barral, S., Reitz, C., Medrano, M., Lantigua, R., et al. (2011). Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch. Neurol. 68, 320-328. doi: 10.1001/archneurol.2010.292.
74. Lee, Y., Samaco, R. C., Gatchel, J. R., Thaller, C., Orr, H. T., and Zoghbi, H. Y. (2008). miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat. Neurosci. 11, 1137-1139. doi: 10.1038/nn.2183.
75. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., et al. (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126. doi: 10.1126/science.2111584.
76. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., et al. (1995a). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977. doi: 10.1126/science.7638622.
77. Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A., Weber, J. L., et al. (1995b). A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973. doi: 10.1126/science.7638621.
78. Li, B., and Sun, H. (2013). miR-26a promotes neurite outgrowth by repressing PTEN expression. Mol. Med. Rep. 8, 676-680. doi: 10.3892/mmr.2013.1534.
79. Li, G., Cheng, H., Zhang, X., Shang, X., Xie, H., Zhang, X., et al. (2012). Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice. Neurol. Sci. 34, 963-969. doi: 10.1007/s10072-012-1173-z.
80. Li, Q., Zhao, H. F., Zhang, Z. F., Liu, Z. G., Pei, X. R., Wang, J. B., et al. (2009). Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience 163, 741-749. doi: 10.1016/j.neuroscience.2009.07.014.
81. Li, S., Kang, L., Zhang, C., Xie, G., Li, N., Zhang, Y., et al. (2013). Effects of dihydrotestosterone on synaptic plasticity of hippocampus in male SAMP8 mice. Exp. Gerontol. 48, 778-785. doi: 10.1016/j.exger.2013.04.014.
82. Li, X., Khanna, A., Li, N., and Wang, E. (2011). Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) 3, 985-1002.
83. Liang, D., Han, G., Feng, X., Sun, J., Duan, Y., and Lei, H. (2012). Concerted perturbation observed in a hub network in Alzheimer's disease. PLoS ONE 7:e40498. doi: 10.1371/journal.pone.0040498.
84. Liu, B., Wu, X., Wang, C., Liu, Y., Zhou, Q., and Xu, K. (2012). MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim. Biophys. Acta 1822, 1692-1704. doi: 10.1016/j.bbadis.2012.07.019.
85. Long, J. M., and Lahiri, D. K. (2011). MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem. Biophys. Res. Commun. 404, 889-895. doi: 10.1016/j.bbrc.2010.12.053.
86. Lopez-Ramos, J. C., Jurado-Parras, M. T., Sanfeliu, C., Acuna-Castroviejo, D., and Delgado-Garcia, J. M. (2012). Learning capabilities and CA1-prefrontal synaptic plasticity in a mice model of accelerated senescence. Neurobiol. Aging 33, 627.e13-627.e26. doi: 10.1016/j.neurobiolaging.2011.04.005.
87. Lou, G., Zhang, Q., Xiao, F., Xiang, Q., Su, Z., Zhang, L., et al. (2012). Intranasal administration of TAT-haFGF((1)(4)(-)(1)(5)(4)) attenuates disease progression in a mouse model of Alzheimer's disease. Neuroscience 223, 225-237. doi: 10.1016/j.neuroscience.2012.08.003.
88. Lucas, D., Delgado-Garcia, J. M., Escudero, B., Albo, C., Aza, A., Acin-Perez, R., et al. (2013). Increased learning and brain long-term potentiation in aged mice lacking DNA polymerase mu. PLoS ONE 8:e53243. doi: 10.1371/journal.pone.0053243.
89. Lukiw, W. J. (2007). Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18, 297-300. doi: 10.1097/WNR.0b013e3280148e8b.
90. Lukiw, W. J., and Alexandrov, P. N. (2012). Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol. Neurobiol. 46, 11-19. doi: 10.1007/s12035-012-8234-4.
91. Lukiw, W. J., Alexandrov, P. N., Zhao, Y., Hill, J. M., and Bhattacharjee, S. (2012). Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport 23, 621-626. doi: 10.1097/WNR.0b013e32835542b0.
92. Lukiw, W. J., and Pogue, A. I. (2007). Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem. 101, 1265-1269. doi: 10.1016/j.jinorgbio.2007.06.004.
93. Ma, F., Wang, H., Chen, B., Wang, F., and Xu, H. (2011). Metallothionein 3 attenuated the apoptosis of neurons in the CA1 region of the hippocampus in the senescence-accelerated mouse/PRONE8 (SAMP8). Arq. Neuropsiquiatr. 69, 105-111. doi: 10.1590/S0004-282X2011000100020.
94. Ma, S. L., Tang, N. L., Zhang, Y. P., Ji, L. D., Tam, C. W., Lui, V. W., et al. (2008). Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese. Neurobiol. Aging 29, 856-860. doi: 10.1016/j.neurobiolaging.2006.12.011.
95. Minichiello, L. (2009). TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10, 850-860. doi: 10.1038/nrn2738.
96. Minichiello, L., Calella, A. M., Medina, D. L., Bonhoeffer, T., Klein, R., and Korte, M. (2002). Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36, 121-137. doi: 10.1016/S0896-6273(02)00942-X.
97. Morley, J. E., Armbrecht, H. J., Farr, S. A., and Kumar, V. B. (2012). The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim. Biophys. Acta 1822, 650-656. doi: 10.1016/j.bbadis.2011.11.015.
98. Morley, J. E., Kumar, V. B., Bernardo, A. E., Farr, S. A., Uezu, K., Tumosa, N., et al. (2000). Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21, 1761-1767. doi: 10.1016/S0196-9781(00)00342-9.
99. Müller, U., Winter, P., and Graeber, M. B. (2013). A presenilin 1 mutation in the first case of Alzheimer's disease. Lancet Neurol. 12, 129-130. doi: 10.1016/S1474-4422(12)70307-1.
100. Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., et al. (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 15, 331-337. doi: 10.1038/nm.1912.
101. Naj, A. C., Jun, G., Beecham, G. W., Wang, L. S., Vardarajan, B. N., Buros, J., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43, 436-441. doi: 10.1038/ng.801.
102. Nozaki, I., Watanabe, T., Kawaguchi, M., Akatsu, H., Tsuneyama, K., Yamamoto, Y., et al. (2007). Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains. Arch. Histol. Cytol. 70, 279-290. doi: 10.1679/aohc.70.279.
103. Obayashi, T., and Kinoshita, K. (2011). COXPRESdb: a database to compare gene coexpression in seven model animals. Nucleic Acids Res. 39, D1016-D1022. doi: 10.1093/nar/gkq1147.
104. Obrenovich, M. E., Smith, M. A., Siedlak, S. L., Chen, S. G., de la Torre, J. C., Perry, G., et al. (2006). Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox. Res. 10, 43-56. doi: 10.1007/BF03033333.
105. Orejana, L., Barros-Minones, L., Jordan, J., Puerta, E., and Aguirre, N. (2012). Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol. Aging 33, 625.e11-625.e20. doi: 10.1016/j.neurobiolaging.2011.03.018.
106. Pallàs, M. (2012). Senescence-Accelerated Mice P8, A Tool to Study Brain Aging and Alzheimer's Disease in a Mouse Model. ISRN Cell Biol. 2012, 1-12. doi: 10.5402/2012/917167.
107. Pallas, M., Camins, A., Smith, M. A., Perry, G., Lee, H. G., and Casadesus, G. (2008). From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J. Alzheimers Dis. 15, 615-624.
108. Pang, K. C., Miller, J. P., Fortress, A., and McAuley, J. D. (2006). Age-related disruptions of circadian rhythm and memory in the senescence-accelerated mouse (SAMP8). Age 28, 283-296. doi: 10.1007/s11357-006-9013-9.
109. Pantieri, R., Pardini, M., Cecconi, M., Dagna-Bricarelli, F., Vitali, A., Piccini, A., et al. (2005). A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. Neurol. Sci. 26, 349-350. doi: 10.1007/s10072-005-0499-1.
110. Park, S. M., and Peter, M. E. (2008). microRNAs and death receptors. Cytokine Growth Factor Rev. 19, 303-311. doi: 10.1016/j.cytogfr.2008.04.011.
111. Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D., and Dittel, B. N. (2007). GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39-48.
112. Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743. doi: 10.1016/j.molcel.2007.05.017.
113. Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., and Abeliovich, A. (2013). Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease. Nature 500, 45-50. doi: 10.1038/nature12415.
114. Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778. doi: 10.1038/376775a0.
115. Satoh, J. (2012). Molecular network analysis of human microRNA targetome: from cancers to Alzheimer's disease. BioData Min. 5, 17. doi: 10.1186/1756-0381-5-17.
116. Sawano, E., Negishi, T., Aoki, T., Murakami, M., and Tashiro, T. (2013). Alterations in local thyroid hormone signaling in the hippocampus of the SAMP8 mouse at younger ages: association with delayed myelination and behavioral abnormalities. J. Neurosci. Res. 91, 382-392. doi: 10.1002/jnr.23161.
117. Schindowski, K., Belarbi, K., and Buee, L. (2008). Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav. 7(Suppl. 1), 43-56. doi: 10.1111/j.1601-183X.2007.00378.x.
118. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Bio. 1, 263-274.
119. Sethupathy, P., Corda, B., and Hatzigeorgiou, A. G. (2006). TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA 12, 192-197. doi: 10.1261/rna.2239606.
120. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., et al. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760. doi: 10.1038/375754a0.
121. Shi, C., Xiao, S., Liu, J., Guo, K., Wu, F., Yew, D. T., et al. (2010a). Ginkgo biloba extract EGb761 protects against aging-associated mitochondrial dysfunction in platelets and hippocampi of SAMP8 mice. Platelets 21, 373-379. doi: 10.3109/09537100903511448.
122. Shi, Y. Q., Huang, T. W., Chen, L. M., Pan, X. D., Zhang, J., Zhu, Y. G., et al. (2010b). Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/Cactivity, REB, and improves cognitive performance in SAMP8 mice. J. Alzheimers Dis. 19, 977-989. doi: 10.3233/JAD-2010-1296.
123. Shih, P. H., Chan, Y. C., Liao, J. W., Wang, M. F., and Yen, G. C. (2010). Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer's disease. J. Nutr. Biochem. 21, 598-605. doi: 10.1016/j.jnutbio.2009.03.008.
124. Song, L., Lin, C., Wu, Z., Gong, H., Zeng, Y., Wu, J., et al. (2011). miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS ONE 6:e25454. doi: 10.1371/journal.pone.0025454.
125. Sureda, F. X., Gutierrez-Cuesta, J., Romeu, M., Mulero, M., Canudas, A. M., Camins, A., et al. (2006). Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8. Exp. Gerontol. 41, 360-367. doi: 10.1016/j.exger.2006.01.015.
126. Tajes, M., Gutierrez-Cuesta, J., Folch, J., Ferrer, I., Caballero, B., Smith, M. A., et al. (2008). Lithium treatment decreases activities of tau kinases in a murine model of senescence. J. Neuropathol. Exp. Neurol. 67, 612-623. doi: 10.1097/NEN.0b013e3181776293.
127. Takei, Y., Assenberg, M., Tsujimoto, G., and Laskey, R. (2002). The MCM3 acetylase MCM3AP inhibits initiation, but not elongation, of DNA replication via interaction with MCM3. J. Biol. Chem. 277, 43121-43125. doi: 10.1074/jbc. C200442200.
128. Takei, Y., Swietlik, M., Tanoue, A., Tsujimoto, G., Kouzarides, T., and Laskey, R. (2001). MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3. EMBO Rep. 2, 119-123. doi: 10.1093/embo-reports/kve026.
129. Tedde, A., Piaceri, I., Bagnoli, S., Lucenteforte, E., Ueberham, U., Arendt, T., et al. (2011). Association study of genetic variants in CDKN2A/CDKN2B genes/loci with late-onset Alzheimer's disease. Int. J. Alzheimers Dis. 2011:374631. doi: 10.4061/2011/374631.
130. Tew, K. L., Li, X. L., and Tan, S. H. (2007). Functional centrality: detecting lethality of proteins in protein interaction networks. Genome Inform. 19, 166-177. doi: 10.1142/9781860949852_0015.
131. Tomobe, K., and Nomura, Y. (2009). Neurochemistry, neuropathology, and heredity in SAMP8, a mouse model of senescence. Neurochem. Res. 34, 660-669. doi: 10.1007/s11064-009-9923-x.
132. Trenkmann, M., Brock, M., Gay, R. E., Michel, B. A., Gay, S., and Huber, L. C. (2013). Tumor necrosis factor alpha-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-kappaB signaling. Arthritis Rheum. 65, 916-927. doi: 10.1002/art.37834.
133. Tseveleki, V., Rubio, R., Vamvakas, S. S., White, J., Taoufik, E., Petit, E., et al. (2010). Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes. Genomics 96, 82-91. doi: 10.1016/j.ygeno.2010.04.004.
134. Ueno, M., Sakamoto, H., Kanenishi, K., Onodera, M., Akiguchi, I., and Hosokawa, M. (2001). Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). Neurobiol. Aging 22, 469-478. doi: 10.1016/S0197-4580(01)00213-5.
135. Verghese, P. B., Castellano, J. M., and Holtzman, D. M. (2011). Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10, 241-252. doi: 10.1016/S1474-4422(10)70325-2.
136. Vilardo, E., Barbato, C., Ciotti, M., Cogoni, C., and Ruberti, F. (2010). MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J. Biol. Chem. 285, 18344-18351. doi: 10.1074/jbc. M110.112664.
137. Vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kalin, R. E., Lopategui-Cabezas, I., et al. (2012). Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat. Med. 18, 1812-1819. doi: 10.1038/nm.2965.
138. Wan, W., Chen, H., and Li, Y. (2013). The potential mechanisms of abeta-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease. Int. J. Neurosci. doi: 10.3109/00207454.2013.825258. [Epub ahead of print].
139. Wang, G., Zhang, Y., Chen, B., and Cheng, J. (2003). Preliminary studies on Alzheimer's disease using cDNA microarrays. Mech. Ageing Dev. 124, 115-124. doi: 10.1016/S0047-6374(02)00188-4.
140. Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., et al. (2010). miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res. 1357, 166-174. doi: 10.1016/j.brainres.2010.08.023.
141. Wang, Y. J., Chen, G. H., Hu, X. Y., Lu, Y. P., Zhou, J. N., and Liu, R. Y. (2005). The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Brain Res. 1031, 101-108. doi: 10.1016/j.brainres.2004.10.061.
142. Wei, J. S., Song, Y. K., Durinck, S., Chen, Q. R., Cheuk, A. T., Tsang, P., et al. (2008). The MYCN oncogene is a direct target of miR-34a. Oncogene 27, 5204-5213. doi: 10.1038/onc.2008.154.
143. Wei, X., Zhang, Y., and Zhou, J. (1999). Alzheimer's disease-related gene expression in the brain of senescence accelerated mouse. Neurosci. Lett. 268, 139-142. doi: 10.1016/S0304-3940(99)00396-1.
144. Wijsman, E. M., Pankratz, N. D., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., et al. (2011). Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 7:e1001308. doi: 10.1371/journal.pgen.1001308.
145. Woodruff-Pak, D. S. (2008). Animal models of Alzheimer's disease: therapeutic implications. J. Alzheimers Dis. 15, 507-521.
146. Wu, B., Ueno, M., Onodera, M., Kusaka, T., Huang, C. L., Hosomi, N., et al. (2009). RAGE, receptor, LDL, and LRP1 expression in the brains of SAMP8. Neurosci. Lett. 461, 100-105. doi: 10.1016/j.neulet.2009.06.013.
147. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., and Li, T. (2009a). miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 37, D105-D110. doi: 10.1093/nar/gkn851.
148. Xiao, X., Wang, Y., Gong, H., Chen, P., and Xie, L. (2009b). Molecular evidence of senescence in corneal endothelial cells of senescence-accelerated mice. Mol. Vis. 15, 747-761.
149. Yaguchi, T., Nagata, T., and Nishizaki, T. (2010). 1, 2-dilinoleoyl-sn-glycero-3-phosphoethanolamine ameliorates age-related spatial memory deterioration by preventing neuronal cell death. Behav. Brain Funct. 6, 52. doi: 10.1186/1744-9081-6-52.
150. Yamaguchi, Y., Saito, K., Matsuno, T., Takeda, K., and Hino, M. (2012). Effects of ZSET1446/ST101 on cognitive deficits and amyloid ??beta; deposition in the senescence accelerated prone mouse brain. J. Pharmacol. Sci. 119, 160-166. doi: 10.1254/jphs.12036FP.
151. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., et al. (1996). RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691. doi: 10.1038/382685a0.
152. Yang, S., Qiao, H., Wen, L., Zhou, W., and Zhang, Y. (2005). D-serine enhances impaired long-term potentiation in CA1 subfield of hippocampal slices from aged senescence-accelerated mouse prone/8. Neurosci. Lett. 379, 7-12. doi: 10.1016/j.neulet.2004.12.033.
153. Yuan, M., Wen-Xia, Z., Jun-Ping, C., and Yong-Xiang, Z. (2005). Age-related changes in the oestrous cycle and reproductive hormones in senescence-accelerated mouse. Reprod. Fertil. Dev. 17, 507-512. doi: 10.1071/RD04099.
154. Zhang, B., Gaiteri, C., Bodea, L. G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., et al. (2013). Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707-720. doi: 10.1016/j.cell.2013.03.030.
155. Zhang, C., Wang, J., Liu, G., and Chen, Q. (2005). Effect of the Chinese traditional medicine "Bushen Yinao Pian" on the cerebral gene expression of the senescence-accelerated mouse prone 8/ta. Am. J. Chin. Med. 33, 639-650. doi: 10.1142/S0192415X05003235.
156. Zhang, G. R., Cheng, X. R., Zhou, W. X., and Zhang, Y. X. (2008). Age-related expression of STUB1 in senescence-accelerated mice and its response to anti-Alzheimer's disease traditional Chinese medicine. Neurosci. Lett. 438, 371-375. doi: 10.1016/j.neulet.2008.04.075.
157. Zhang, G. R., Cheng, X. R., Zhou, W. X., and Zhang, Y. X. (2009). Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs. Neuroscience 159, 308-315. doi: 10.1016/j.neuroscience.2008.06.068.
158. Zheng, Y., Cheng, X. R., Zhou, W. X., and Zhang, Y. X. (2008). Gene expression patterns of hippocampus and cerebral cortex of senescence-accelerated mouse treated with Huang-Lian-Jie-Du decoction. Neurosci. Lett. 439, 119-124. doi: 10.1016/j.neulet.2008.04.009.
159. Zhu, Y., Lee, C. C., Lam, W. P., Wai, M. S., Rudd, J. A., and Yew, D. T. (2007). Cell death in the Purkinje cells of the cerebellum of senescence accelerated mouse (SAMP(8)). Biogerontology 8, 537-544. doi: 10.1007/s10522-007-9097-3.
160. Zuccato, C., and Cattaneo, E. (2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol. 5, 311-322. doi: 10.1038/nrneurol.2009.54.
161. Zuchner, S., Gilbert, J. R., Martin, E. R., Leon-Guerrero, C. R., Xu, P. T., Browning, C., et al. (2008). Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. Ann. Hum. Genet. 72, 725-731. doi: 10.1111/j.1469-1809.2008.00474.x.